BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25891519)

  • 1. Long-term outcomes in a high-risk bladder cancer screening cohort.
    Starke N; Singla N; Haddad A; Lotan Y
    BJU Int; 2016 Apr; 117(4):611-7. PubMed ID: 25891519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
    BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
    Lotan Y; Shariat SF;
    BJU Int; 2008 Jun; 101(11):1362-7. PubMed ID: 18284410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
    Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
    BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
    Lotan Y; Capitanio U; Shariat SF; Hutterer GC; Karakiewicz PI
    BJU Int; 2009 May; 103(10):1368-74. PubMed ID: 19338566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Pietzak EJ; Mucksavage P; Guzzo TJ; Malkowicz SB
    Urology; 2015 Nov; 86(5):968-72. PubMed ID: 26190088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
    Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
    Lotan Y; Elias K; Svatek RS; Bagrodia A; Nuss G; Moran B; Sagalowsky AI
    J Urol; 2009 Jul; 182(1):52-7; discussion 58. PubMed ID: 19450825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urological implications of concurrent bladder and lung cancer.
    Vainrib M; Leibovitch I
    Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
    Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
    Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival.
    Kroeger N; Klatte T; Birkhäuser FD; Rampersaud EN; Seligson DB; Zomorodian N; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    Cancer; 2012 Apr; 118(7):1795-802. PubMed ID: 21997347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
    Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
    BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    Ramirez D; Gupta A; Canter D; Harrow B; Dobbs RW; Kucherov V; Mueller E; Streeper N; Uhlman MA; Svatek RS; Messing EM; Lotan Y
    BJU Int; 2016 May; 117(5):783-6. PubMed ID: 26435378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
    Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
    BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
    Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
    Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder.
    Sfakianos JP; Shariat SF; Favaretto RL; Rioja J; Herr HW
    BJU Int; 2011 Aug; 108(4):526-30. PubMed ID: 21114611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.